Insilico Medicine approves HK$500 million share buyback
AI Summary- Insilico Medicine's board approved an open-market share repurchase program.
- HK$500 million, or approximately $63.7 million, is the total buyback cap.
- The company will fund purchases with its own financial resources across multiple tranches.